CLINICAL_TRIALS
trial_result
· 2024-07-01
Clinical Trial Update: Prednisone in Cystic Fibrosis Pulmonary Exacerbations [Phase 3]
Summary
Phase 3 trial update on prednisone for pulmonary exacerbations in cystic fibrosis; the study status is completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Hospital for Sick Children | Conditions: Cystic Fibrosis Pulmonary Exacerbation | Phase 3 | Status: COMPLETED